Adegboyega Bolanle C, Alabi Adewumi O, Joseph Adedayo O, Lasebikan Nwamaka, Agaga Luther A, Ololade Kehinde O, Sowunmi Anthonia C
Department of Radiotherapy, Lagos University Teaching Hospital, Idi Araba Mushin, Lagos, 234, Nigeria.
Department of Radiation Biology, Radiotherapy and Radiodiagnosis, College of Medicine, University of Lagos, Idi Araba Mushin, Lagos, 234, Nigeria.
Ecancermedicalscience. 2021 Sep 23;15:1294. doi: 10.3332/ecancer.2021.1294. eCollection 2021.
Breast cancer management is evolving by the day and new discoveries is shifting the scale to more positive result mostly in developed countries and this is being reported and updated in the treatment guidelines to bridge the knowledge gaps and allow for global standardised management protocol. This study assessed the adherence to the breast cancer guideline use among oncologists in Nigeria, reviewing the commonly used guidelines, factors for the choice, effects on treatment and barriers to usage.
A proforma was sent by mail to the oncologist in Nigeria assessing their socio-demographic characteristics, knowledge of guidelines, use of guidelines, barriers to use of guidelines and benefits of guideline use and all the those that completed the survey within 1-month period were included in the study.
A total of 109 oncologist responded to the survey with mean age of 42 years, mean year of oncology practice was 10 years. Sixty-four percent were consultants and 38% residents-in-training. All respondents were aware of breast cancer guidelines and 92.2% had used it in treatment decision making. The commonest used being National Comprehensive Cancer Network guideline in 87.4% and 82.6% had a choice guideline/institution adopted. The major reason for referring to a choice guideline by 66% of respondents was to gain access to evidence-based results and the major barrier to guideline use in 56% of cases was non compatibility with available resources.
The study revealed high level of adherence to breast cancer guideline use among oncologists in Nigeria but there is need for more awareness about the locally developed ones like sub-Saharan adapted version and institutional based breast cancer treatment guidelines so as to address the barrier of disparities in target population and resources availability.
乳腺癌的治疗方法日新月异,新发现正使治疗结果朝着更积极的方向发展,这一情况在发达国家尤为明显。治疗指南不断更新,以填补知识空白,实现全球标准化管理方案。本研究评估了尼日利亚肿瘤学家对乳腺癌指南的遵循情况,回顾了常用指南、选择指南的因素、对治疗的影响以及使用指南的障碍。
通过邮件向尼日利亚的肿瘤学家发送一份表格,评估他们的社会人口学特征、对指南的了解程度、指南的使用情况、使用指南的障碍以及使用指南的益处。在1个月内完成调查的所有人员均纳入研究。
共有109名肿瘤学家回复了调查,平均年龄42岁,平均肿瘤学从业年限为10年。64%为顾问医生,38%为住院医师。所有受访者均知晓乳腺癌指南,92.2%在治疗决策中使用过该指南。最常用的是美国国立综合癌症网络(National Comprehensive Cancer Network)指南,占87.4%,82.6%的人选择了特定指南/机构采用的指南。66%的受访者参考特定指南的主要原因是获取循证结果,56%的病例中使用指南的主要障碍是与现有资源不匹配。
该研究表明,尼日利亚肿瘤学家对乳腺癌指南的遵循程度较高,但需要提高对当地制定的指南(如撒哈拉以南适应版和基于机构的乳腺癌治疗指南)的认识,以解决目标人群差异和资源可及性方面的障碍。